medigraphic.com
ISSN 1405-1710 (Print)

2016, Number 1

<< Back Next >>

Rev Cent Dermatol Pascua 2016; 25 (1)

Acute generalized exanthematous pustulosis. A case report and literature review

Jurado SCF, Cardona HMÁ, Ramos GA, Rossiere ENL, Ríos GZ

Language: Spanish
References: 15
Page: 27-31
PDF size: 323.18 Kb.


ABSTRACT

Acute generalized exanthematous pustulosis (AGEP) is a rare drug-induced skin disorder. It is characterized by the rapid onset of disseminated sterile nonfollicular pustules, that are accompanied by fever and marked neutrophilia. The correct diagnosis of this disease is challenging due to its similarity with pustular psoriasis of Von Zumbusch. This disease will have a favorable prognosis when the causative drug is withdrawn. In this article we present a case of a 48 year old female with AGEP associated to Dicloxacillin, and we did a brief review of the literature.


REFERENCES

  1. De Sousa AS, Lara OAC de C, Papaiordanou F, Marchioro GSS, Tebcherani AJ. Acute generalized exanthematous pustulosis vs Von Zumbusch’s pustular psoriasis: a diagnostic challenge in a psoriatic patient. An Bras Dermatol. 2015; 90: 557-560.

  2. Harr T, French LE. Severe cutaneous adverse reactions: acute generalized exanthematous pustulosis, toxic epidermal necrolysis and Stevens-Johnson syndrome. Med Clin North Am. 2010; 94: 727-742.

  3. Sidoroff A, Halevy S, Bavinck JN, Vaillant L, Roujeau JC. Acute generalized exanthematous pustulosis (AGEP)--a clinical reaction pattern. J Cutan Pathol. 2001; 28: 113-119.

  4. Guevara-Gutierrez E, Uribe-Jimenez E, Diaz-Canchola M, Tlacuilo-Parra A. Acute generalized exanthematous pustulosis: report of 12 cases and literature review. Int J Dermatol. 2009; 48: 253-258.

  5. Lee YY, Chung WH. Acute generalized exanthematous pustulosis: a retrospective study of 51 cases in Taiwan. Dermatologica Sin. 2014; 32: 137-140.

  6. Fernando SL. Acute generalised exanthematous pustulosis. Australas J Dermatol. 2012; 53: 87-92.

  7. Roujeau JC, Bioulac-Sage P, Bourseau C et al. Acute generalized exanthematous pustulosis. Analysis of 63 cases. Arch Dermatol. 1991; 127: 1333-1338.

  8. Burrows NP, Russell Jones RR. Pustular drug eruptions: a histopathological spectrum. Histopathology. 1993; 22: 569-573.

  9. Lazarov A, Livni E, Halevy S. Generalized pustular drug eruptions: confirmation by in vitro tests. J Eur Acad Dermatol Venereol. 1998; 10: 36-41.

  10. Cohen A, Cagnano E, Halevy S. Acute generalized exanthematous pustulosis mimicking toxic epidermal necrolysis. Int J Dermatol. 2001; 40: 458-461.

  11. Sidoroff A, Dunant A, Viboud C et al. Risk factors for acute generalized exanthematous pustulosis (AGEP)-results of a multinational case-control study (EuroSCAR). Br J Dermatol. 2007; 157: 989e96.

  12. Davidovici BB, Pavel D, Cagnano E, Rozenman D, Halevy S, EuroSCAR, RegiSCAR study group. Acute generalized exanthematous pustulosis following a spider bite: report of 3 cases. J Am Acad Dermatol. 2006; 55: 525e9.

  13. Hotz C, Valeyrie-Allanore L, Haddad C et al. Systemic involvement of acute generalized exanthematous pustulosis: a retrospective study on 58 patients. Br J Dermatol. 2013; 169: 1223e32.

  14. Criado PRi, Criado RFJ, Vasconcellos C, Ramos RO, Gonçalves AC. Severe cutaneous adverse drug reactions-relevant aspects to diagnosis and treatment -Part II. An Bras Dermatol. 2004; 79: 587-601.

  15. Yong-Kwang T, Siew-Nee T. The profile and outcome of pustular psoriasis in Singapore: a report of 28 cases. Int J Dermatol. 1997; 36: 266-271.




2020     |     www.medigraphic.com